Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Atorvastatin’s Role in Enhancing Immunotherapy for Patients with Triple Negative Breast Cancer and Non-Small Cell Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients
Recruiting
Investigated Diseases:Investigated Drugs:
+6
Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
Recruiting
Investigated Drugs:
+3
Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Recruiting
Investigated Drugs:
+1
Study Comparing Atezolizumab Alone and Atezolizumab with Bevacizumab for First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
Recruiting
Investigated Diseases:Investigated Drugs:
+5
Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
Study on the Effectiveness and Safety of Carboplatin, Pemetrexed, and Lorlatinib for ALK Positive Non-Small Cell Lung Cancer with Extracranial Progression
Recruiting
Investigated Diseases:Investigated Drugs:
Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs: